OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ginsenoside Rg3-loaded, reactive oxygen species-responsive polymeric nanoparticles for alleviating myocardial ischemia-reperfusion injury
Lan Li, Yili Wang, Rui Guo, et al.
Journal of Controlled Release (2019) Vol. 317, pp. 259-272
Open Access | Times Cited: 143

Showing 1-25 of 143 citing articles:

Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries
Tianjiao Zhao, Wei Wu, Sui Li-hua, et al.
Bioactive Materials (2021) Vol. 7, pp. 47-72
Open Access | Times Cited: 216

Bioresponsive drug delivery systems for the treatment of inflammatory diseases
Yin Dou, Chenwen Li, Lanlan Li, et al.
Journal of Controlled Release (2020) Vol. 327, pp. 641-666
Open Access | Times Cited: 159

Reactive Oxygen Species Scavenging Nanomedicine for the Treatment of Ischemic Heart Disease
Zhan Zhang, Rinkoo Dalan, Zhenyu Hu, et al.
Advanced Materials (2022) Vol. 34, Iss. 35
Open Access | Times Cited: 106

ROS-triggered self-disintegrating and pH-responsive astaxanthin nanoparticles for regulating the intestinal barrier and colitis
Xuedi Zhang, Xue Zhao, Zheng Hua, et al.
Biomaterials (2022) Vol. 292, pp. 121937-121937
Closed Access | Times Cited: 70

M2 Macrophage‐Derived sEV Regulate Pro‐Inflammatory CCR2+ Macrophage Subpopulations to Favor Post‐AMI Cardiac Repair
Lan Li, Jiasong Cao, Sheng Li, et al.
Advanced Science (2023) Vol. 10, Iss. 14
Open Access | Times Cited: 44

The pathological mechanisms and potential therapeutic drugs for myocardial ischemia reperfusion injury
Shuo Zhang, Fei Yan, Fei Luan, et al.
Phytomedicine (2024) Vol. 129, pp. 155649-155649
Closed Access | Times Cited: 17

Functional roles and mechanisms of ginsenosides from Panax ginseng in atherosclerosis
Qianqian Xue, Ningning He, Zhibin Wang, et al.
Journal of Ginseng Research (2020) Vol. 45, Iss. 1, pp. 22-31
Open Access | Times Cited: 93

Reactive Oxygen Species (ROS)-Responsive Nanomedicine for Solving Ischemia-Reperfusion Injury
Weiyu Chen, Deling Li
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 80

Ginsenoside Rg3 attenuates angiotensin II-induced myocardial hypertrophy through repressing NLRP3 inflammasome and oxidative stress via modulating SIRT1/NF-κB pathway
Bei Ren, Jinping Feng, Ning Yang, et al.
International Immunopharmacology (2021) Vol. 98, pp. 107841-107841
Open Access | Times Cited: 80

Nanotheranostics for the Management of Hepatic Ischemia‐Reperfusion Injury
Yu Guan, Weifeng Yao, Ke Yi, et al.
Small (2021) Vol. 17, Iss. 23
Closed Access | Times Cited: 75

Emerging nanoformulation strategies for phytocompounds and applications from drug delivery to phototherapy to imaging
Hwa Seung Han, Dae‐Geun Song, Ki Young Choi
Bioactive Materials (2021) Vol. 14, pp. 182-205
Open Access | Times Cited: 64

Nano-traditional Chinese medicine: a promising strategy and its recent advances
Daohe Wei, Han Yang, Yue Zhang, et al.
Journal of Materials Chemistry B (2022) Vol. 10, Iss. 16, pp. 2973-2994
Closed Access | Times Cited: 63

An injectable co-assembled hydrogel blocks reactive oxygen species and inflammation cycle resisting myocardial ischemia-reperfusion injury
Xu Liao, Xudong Song, Jiejing Li, et al.
Acta Biomaterialia (2022) Vol. 149, pp. 82-95
Closed Access | Times Cited: 56

Biosensor-Integrated Drug Delivery Systems as New Materials for Biomedical Applications
Iwona Cicha, Ronny Priefer, Patrícia Severino, et al.
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1198-1198
Open Access | Times Cited: 44

Amelioration of colitis progression by ginseng-derived exosome-like nanoparticles through suppression of inflammatory cytokines
Jisu Kim, Shuya Zhang, Ying Zhu, et al.
Journal of Ginseng Research (2023) Vol. 47, Iss. 5, pp. 627-637
Open Access | Times Cited: 42

Nanomaterials: A Promising Therapeutic Approach for Cardiovascular Diseases
Hitesh Chopra, Shabana Bibi, Awdhesh Kumar Mishra, et al.
Journal of Nanomaterials (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 41

Preparation and bioactivity of the rare ginsenosides Rg3 and Rh2: An updated review
Wenqi Xu, Lyu Wei, Cuicui Duan, et al.
Fitoterapia (2023) Vol. 167, pp. 105514-105514
Closed Access | Times Cited: 31

Biomaterials-mediated targeted therapeutics of myocardial ischemia-reperfusion injury
Qiang Luo, Wei Sun, Zhibo Li, et al.
Biomaterials (2023) Vol. 303, pp. 122368-122368
Closed Access | Times Cited: 26

Chemotactic NO/H2S Nanomotors Realizing Cardiac Targeting of G-CSF against Myocardial Ischemia-Reperfusion Injury
Nan Li, Chenxing Huang, Jie Zhang, et al.
ACS Nano (2023) Vol. 17, Iss. 13, pp. 12573-12593
Closed Access | Times Cited: 24

Biomaterials-Based Antioxidant Strategies for the Treatment of Oxidative Stress Diseases
Maria Pérez-Araluce, Tomasz Jüngst, Carmen Sanmartín, et al.
Biomimetics (2024) Vol. 9, Iss. 1, pp. 23-23
Open Access | Times Cited: 14

Recent advancements in nanotechnology based drug delivery for the management of cardiovascular disease
Aziz Ullah, Muneeb Ullah, Sung In Lim
Current Problems in Cardiology (2024) Vol. 49, Iss. 4, pp. 102396-102396
Closed Access | Times Cited: 11

Management of ROS and Regulatory Cell Death in Myocardial Ischemia–Reperfusion Injury
Ge Gong, Wenhui Wan, Xinghu Zhang, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 10

Page 1 - Next Page

Scroll to top